HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ghulam J Mufti Selected Research

Refractory Anemia with Excess of Blasts (RAEM)

12/2010Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.
8/2010Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*.
4/2010Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.
11/2007Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ghulam J Mufti Research Topics

Disease

35Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2014 - 10/2002
11Neoplasms (Cancer)
01/2015 - 04/2003
11Graft vs Host Disease (Graft-Versus-Host Disease)
11/2014 - 10/2002
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2014 - 09/2004
4Disease Progression
05/2015 - 01/2006
4Chromosomal Instability (Chromosome Stability)
09/2013 - 04/2002
4Leukemia
09/2012 - 12/2005
4Refractory Anemia with Excess of Blasts (RAEM)
12/2010 - 11/2007
4Myeloid Leukemia (Leukemia, Myelocytic)
05/2009 - 05/2002
3Infection
09/2015 - 07/2005
3Aplastic Anemia (Anemia, Hypoplastic)
11/2014 - 08/2011
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2014 - 04/2008
3Thrombocytopenia (Thrombopenia)
06/2014 - 10/2009
3Lymphoma (Lymphomas)
07/2012 - 07/2005
3Chromosome Aberrations (Chromosome Abnormalities)
01/2009 - 04/2002
3Hematologic Neoplasms (Hematological Malignancy)
09/2007 - 02/2004
2Neutropenia
04/2014 - 11/2006
2Budd-Chiari Syndrome (Budd Chiari Syndrome)
07/2012 - 06/2006
2Multiple Myeloma
06/2012 - 07/2006
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2006 - 09/2002
2Testicular Neoplasms (Testicular Cancer)
10/2005 - 08/2005
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2015
1Mycoses (Diseases, Fungus)
01/2015
1Human Influenza (Influenza)
01/2015
1HIV Infections (HIV Infection)
11/2014
1Hemorrhage
06/2014
1Hematologic Diseases (Blood Diseases)
06/2014
1Hypersensitivity (Allergy)
09/2013
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
09/2013
1Vitreous Hemorrhage
09/2013
1Pancytopenia
09/2013
1Microsatellite Instability
09/2013
1Retinal Neovascularization
09/2013
1Myeloproliferative Disorders (Myeloproliferative Disorder)
07/2012
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2012
1Bone Resorption
06/2012
1Pemphigus (Pemphigus Vulgaris)
09/2011
1Skin Manifestations
09/2011
1Plasma Cell Leukemia
04/2011
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2010
1Refractory Anemia
08/2010
1Primary Myelofibrosis (Myelosclerosis)
10/2009

Drug/Important Bio-Agent (IBA)

13alemtuzumab (Campath)FDA Link
07/2014 - 09/2002
11Azacitidine (5 Azacytidine)FDA Link
04/2014 - 12/2005
5fludarabineIBA
08/2011 - 09/2004
4lenalidomide (CC 5013)FDA Link
05/2015 - 05/2008
4AntigensIBA
01/2015 - 08/2005
4DNA (Deoxyribonucleic Acid)IBA
08/2013 - 04/2002
4Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2012 - 10/2002
4Cytarabine (Cytosar-U)FDA LinkGeneric
08/2010 - 04/2008
41,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
09/2007 - 04/2002
3romiplostimFDA Link
11/2014 - 10/2009
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014 - 07/2006
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2013 - 12/2008
3rituximab (Mabthera)FDA Link
09/2011 - 01/2004
3Busulfan (Busulfex)FDA Link
08/2007 - 09/2004
2Thrombopoietin ReceptorsIBA
11/2014 - 10/2009
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
11/2013 - 06/2012
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2012 - 08/2006
2iodonitrotetrazolium (INT)IBA
12/2010 - 08/2010
24-1BB Ligand (4 1BB Ligand)IBA
03/2009 - 03/2004
25q- syndromeIBA
01/2009 - 11/2007
2imatinib (Gleevec)FDA Link
02/2004 - 04/2003
2Proteins (Proteins, Gene)IBA
04/2003 - 05/2002
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2015
1Viral AntigensIBA
01/2015
1Sodium Glutamate (Accent)IBA
01/2015
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2015
1MART-1 AntigenIBA
01/2015
1EpitopesIBA
01/2015
1eltrombopagFDA Link
11/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2014
1ErythropoietinFDA Link
11/2014
1HematinicsIBA
11/2014
1MDS 004IBA
11/2014
1Retinaldehyde (Retinal)IBA
09/2013
1Fluorescein (Funduscein)FDA LinkGeneric
09/2013
1Messenger RNA (mRNA)IBA
07/2013
1Janus Kinase 2IBA
07/2012
1daclizumab (dacliximab)FDA Link
07/2012
1thymoglobulinIBA
06/2012
1Phosphotransferases (Kinase)IBA
06/2012
1Azathioprine (Imuran)FDA LinkGeneric
09/2011
1SteroidsIBA
09/2011
1NF-kappa B (NF-kB)IBA
10/2010
1Reticulin (Reticular Fiber)IBA
10/2009
1Inosine Triphosphate (ITP)IBA
10/2009
1First StepIBA
08/2009

Therapy/Procedure

13Stem Cell Transplantation
11/2014 - 10/2002
13Transplants (Transplant)
11/2014 - 11/2005
12Hematopoietic Stem Cell Transplantation
01/2015 - 09/2002
10Transplantation (Transplant Recipients)
01/2015 - 08/2006
6Drug Therapy (Chemotherapy)
01/2011 - 01/2006
5Homologous Transplantation (Allograft)
09/2012 - 03/2007
3Immunotherapy
01/2015 - 03/2004
2Liver Transplantation
07/2012 - 07/2005
1Erythrocyte Transfusion
11/2014
1Platelet Transfusion (Blood Platelet Transfusions)
06/2014
1Radiotherapy
01/2011
1Aftercare (After-Treatment)
10/2009